Page 125 - Vitamin D and Cancer

112 Y. Ma et al.

79. Oikawa T, Hirotani K, Ogasawara H, Katayama T, Nakamura O, Iwaguchi T, Hiragun A
(1990) Inhibition of angiogenesis by vitamin D3 analogues. Eur J Pharmacol
178:247–250
80. Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS
(2009) Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-
derived endothelial cells and tumor angiogenesis in vivo. Cancer Res 69:967–975
81. Shokravi MT, Marcus DM, Alroy J, Egan K, Saornil MA, Albert DM (1995) Vitamin D
inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci
36:83–87
82. Fujioka T, Hasegawa M, Ishikura K, Matsushita Y, Sato M, Tanji S (1998) Inhibition of
tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma. J Urol
160:247–251
83. Iseki K, Tatsuta M, Uehara H, Iishi H, Yano H, Sakai N, Ishiguro S (1999) Inhibition of
angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1, 25-dihy-
droxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J
Cancer 81:730–733
84. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T (2005) 22-Oxa-1alpha, 25-dihy-
droxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis
26:1044–1054
85. Suzuki T, Sano Y, Kinoshita S (2000) Effects of 1alpha, 25-dihydroxyvitamin D3 on
Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis
Sci 41:154–158
86. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W (1993) Inhibition of tumor
cell-induced angiogenesis by retinoids, 1, 25-dihydroxyvitamin D3 and their combination.
Cancer Lett 75:35–39
87. Majewski S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S (1996) Vitamin
D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Investig Dermatol Symp Proc
1:97–101
88. Nowicka D, Zagozdzon R, Majewski S, Marczak M, Jablonska S, Bollag W (1998) Calcitriol
enhances antineoplastic and antiangiogenic effects of interleukin-12. Arch Dermatol Res
290:696–700
89. Lin R, Amizuka N, Sasaki T, Aarts MM, Ozawa GD, Henderson JE, White JH (2002)
1Alpha, 25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseous junction
by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase
9. J Bone Miner Res 17:1604–1612
90. Okuda N, Takeda S, Shinomiya K, Muneta T, Itoh S, Noda M, Asou Y (2007) ED-71, a novel
vitamin D analog, promotes bone formation and angiogenesis and inhibits bone resorption
after bone marrow ablation. Bone 40:281–292
91. Bao BY, Yao J, Lee YF (2006) 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-
mediated prostate cancer cell angiogenesis. Carcinogenesis 27:1883–1893
92. Melillo G (2006) Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res
4:601–605
93. Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ (2007) 1alpha,
25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothe-
lial growth factor pathway in human cancer cells. Mol Cancer Ther 6:1433–1439
94. Shan JJ, Li B, Taniguchi N, Pang PK (1996) Inhibition of membrane L-type calcium channel
activity and intracellular calcium concentration by 24R, 25-dihydroxyvitamin D3 in vascular
smooth muscle. Steroids 61:657–663
95. Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK (1993) 1,
25-Dihydroxyvitamin D as a cardiovascular hormone. Effects on calcium current and
cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 6:983–988
96. Kawashima H (1988) 1, 25-Dihydroxyvitamin D3 stimulates Ca-ATPase in a vascular
smooth muscle cell line. Biochem Biophys Res Commun 150:1138–1143